CV
EVFM

Clarus Ventures’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Clarus Ventures’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,905
Closed -$8.65M – 8
2015
Q3 		$8.65M Hold
11,905
– – 4.97% 6
2015
Q2 		$9.64M Hold
11,905
– – 4.24% 7
2015
Q1 		$8.8M Hold
11,905
– – 3.66% 7
2014
Q4 		$8.01M Buy
+11,905
New +$8.99M 2.29% 8

Other funds holding EVFM

CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Clarus Ventures's EVFM Position: Q4 2015 in Review

Clarus Ventures sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2015, closing a stake of 11,905 shares — an estimated $8.65M sold.

Clarus Ventures first reported a position in EVFM in Q4 2014 and held it in 4 quarters. The position peaked at $9.64M in Q2 2015. 24 funds tracked by Wall St. Rank hold EVFM as of Q4 2015.

  • Clarus Ventures reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Clarus Ventures sold 11,905 Evofem Biosciences, Inc. Common Stock shares in Q4 2015, an estimated $8.65M.
  • Clarus Ventures first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 4 quarters.
  • Clarus Ventures's Evofem Biosciences, Inc. Common Stock position peaked at $9.64M in Q2 2015.
  • 24 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2015.

Based on Clarus Ventures's 13F filing for Q4 2015, filed 25 Jan 2016.